Showing results (671-680 of 1,548) with videos related to
Sort By:
Pageof 155
Cancer Reports (Hoboken, N.J.)|August 15, 2020
Development and validation of an immune prognostic signature for ovarian carcinomaSeema Khadirnaikar, Pranjal Kumar, Sudhanshu Kumar ShuklaCancer Reports (Hoboken, N.J.)|August 13, 2025
Flavonoids as Promising Akt1 Inhibitors in Cancer Medicine: Insights From Molecular Docking, Dynamics, DFT Calculations, and In Vitro ValidationShokoofeh Jamshidi, Ali Eghbalian, Setareh Shojaei, et al.Cancer Reports (Hoboken, N.J.)|August 12, 2025
Real-World Response and Survival Outcomes and Treatment Patterns in Patients With Extensive Stage Small-Cell Lung Cancer Receiving Third-Line TreatmentJair Bar, Qingqing Xu, Sudeep Karve, et al.Cancer Reports (Hoboken, N.J.)|August 10, 2025
OncoTrace-TOO: Interpretable Machine Learning Framework for Cancer Tissue-of-Origin Identification Using Transcriptomic SignaturesYang Hao, Haochun Huang, Daiyun Huang, et al.Cancer Reports (Hoboken, N.J.)|August 7, 2025
Development and Validation of Survival Prediction Models for Patients With Pineoblastomas Using Deep Learning: A SEER-Based StudyXuanzi Li, Shuai Yang, Yingpeng Peng, et al.Cancer Reports (Hoboken, N.J.)|August 5, 2025
Population-Based Survival Analysis of Solitary Plasmacytoma of Spine in the United States From 2000 to 2020Kevin E Agner, Luke G Comisford, Alec G Kotler, et al.Cancer Reports (Hoboken, N.J.)|August 3, 2025
Targeting the mTOR Signaling Pathway Through miR-100 and miR-101 in De Novo Acute Myeloid Leukemia: Implications for Therapeutic InterventionMaryam Kargar, Mehdi Allahbakhshian Farsani, Javad Garavand, et al.Cancer Reports (Hoboken, N.J.)|July 30, 2025
The Role of PIWI-Interacting RNA in Urologic Carcinoma and Its Clinical ImplicationsJiajia Cai, Shirui Jiang, Dongdong Lu, et al.Cancer Reports (Hoboken, N.J.)|November 13, 2025
Exploring Challenges Related to Breast Cancer Chemotherapy Among Females in Pakistan: A Qualitative StudyRehana Sarwat, Muhammad Amir Hamza, Ayesha Azam, et al.Cancer Reports (Hoboken, N.J.)|November 11, 2025
Real-World Outcomes of Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma: Analyzing Patient-Specific Factors Influencing Survival and Response RateLena Huber, Constanze Kohler, Anne Lammert, et al.Pageof 155